Is Godavari Drugs Ltd debt-free?

No, Godavari Drugs Ltd is not debt-free with a debt-to-equity ratio of 1.42.

Home

Godavari Drugs Ltd

Godavari Drugs Ltd Financials

Godavari Drugs Ltd Financial Statement

Godavari Drugs Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Jun 2025	Mar 2025	Dec 2024
Revenue	23.82	25.61	29.65
Operating Expense	20.91	22.39	26.97
Net Profit	1.04	0.89	0.77
Net Profit Margin	4.37	3.48	2.60
Earning Per Share	1.38	1.19	1.02
EBIDTA	2.90	3.22	2.67
Effective Tax Rate	8.93	17.08	5.60

Particulars	Jun 2025
Revenue	23.82
Operating Expense	20.91
Net Profit	1.04
Net Profit Margin	4.37
Earning Per Share	1.38
EBIDTA	2.90
Effective Tax Rate	8.93

Godavari Drugs Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	113.35	156.71	159.62
Operating Expenses Annual	101.52	143.41	149.70
Operating Profit Annual	12.81	13.83	10.81
Interest Annual	4.73	4.92	3.93
Depreciation	2.45	1.99	1.94
Net Profit Annual	4.38	5.55	3.79
Tax Annual	1.25	1.37	1.15

Particulars	Mar 2025
Total Revenue Annual	113.35
Operating Expenses Annual	101.52
Operating Profit Annual	12.81
Interest Annual	4.73
Depreciation	2.45
Net Profit Annual	4.38
Tax Annual	1.25

Godavari Drugs Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	2.62	3.08	2.28
Cash Flow from Operations	11.20	18.41	13.22
Cash Flow from Investing	-19.51	-13.22	-8.64
Cash Flow from Financing	8.07	-5.65	-3.77
Cash Flow at the End	2.37	2.62	3.08

Particulars	Mar 2025
Cash Flow at the Beginning	2.62
Cash Flow from Operations	11.20
Cash Flow from Investing	-19.51
Cash Flow from Financing	8.07
Cash Flow at the End	2.37

Godavari Drugs Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
PBDIT Margin (%)	11.29	8.83	6.77
PBIT Margin (%)	9.13	7.56	5.56
PBT Margin (%)	7.20	6.02	4.14
Net PROFIT Margin (%)	3.86	3.54	2.37
Return On Networth / Equity (%)	10.64	15.33	12.02
Return On Networth /Employed (%)	10.06	14.14	14.37
Return On Assets (%)	4.25	6.62	6.15
Total Debt / Equity (X)	1.48	1.29	0.93
Asset Turnover Ratio (%)	1.10	1.87	2.59

Particulars	Mar 2025
PBDIT Margin (%)	11.29
PBIT Margin (%)	9.13
PBT Margin (%)	7.20
Net PROFIT Margin (%)	3.86
Return On Networth / Equity (%)	10.64
Return On Networth /Employed (%)	10.06
Return On Assets (%)	4.25
Total Debt / Equity (X)	1.48
Asset Turnover Ratio (%)	1.10

Godavari Drugs Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	32.61	26.68	24.91
Total Current Assets Annual	78.76	88.48	87.01
Non Current Assets Annual	64.31	46.27	34.43
Total Shareholders Funds Annual	43.35	38.97	33.42
Total Assets Annual	143.08	134.75	121.43

Particulars	Mar 2025
Fixed Assets Annual	32.61
Total Current Assets Annual	78.76
Non Current Assets Annual	64.31
Total Shareholders Funds Annual	43.35
Total Assets Annual	143.08

Godavari Drugs Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Godavari Drugs Ltd Financials

As of Sep 18, 2025, Godavari Drugs Ltd has a market capitalization of 65.86 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Godavari Drugs Ltd is not with a debt-to-equity ratio of 1.42.

In FY 2024 , Godavari Drugs Ltd recorded a total revenue of approximately 113.35 Cr marking a significant milestone in the company's financial performance.

Godavari Drugs Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and -0.2% annually, respectively..

Godavari Drugs Ltd's current PE ratio is 15.04.

Godavari Drugs Ltd's ROCE averaged 10.8% from the FY ending March 2023 to 2025, with a median of 10.0%. It peaked at 12.5% in March 2024, reflecting strong capital efficiency over the period..

Godavari Drugs Ltd's latest EBIT is Rs. 10.36 Cr, surpassing the average EBIT of Rs. 10.35 Cr over the 5 years..